moxifloxacin has been researched along with gentamicin in 26 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (gentamicin) | Trials (gentamicin) | Recent Studies (post-2010) (gentamicin) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 19,191 | 1,365 | 3,650 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.85) | 18.2507 |
| 2000's | 10 (38.46) | 29.6817 |
| 2010's | 12 (46.15) | 24.3611 |
| 2020's | 3 (11.54) | 2.80 |
| Authors | Studies |
|---|---|
| Heisig, P; Jones, ME; Klootwijk, M; Schmitz, FJ; Verhoef, J; Visser, MR | 1 |
| Bottura, P; Capra, R; Maggiolo, F; Migliorino, M; Pravettoni, G; Suter, F | 1 |
| Coleman, EJ; Mandell, GL | 1 |
| Botzenhart, K; Dalhoff, A; Döring, G; Kaygin, H; Steinhuber, A; Worlitzsch, D | 1 |
| Carryn, S; Mingeot-Leclercq, MP; Tulkens, PM; Van Bambeke, F | 2 |
| Seral, C; Tulkens, PM; Van Bambeke, F | 1 |
| Bittner, T; Brade, V; Cinatl, J; Hunfeld, KP; Rödel, R | 1 |
| Dahl, P; Hu, DN; Koplin, RS; McCormick, S; Meskin, SW; Ritterband, DC; Seedor, JA; Shah, MK; Shao, S; Shapiro, DE | 1 |
| Arda, B; Calik, S; Pullukcu, H; Sipahi, H; Sipahi, OR; Tasbakan, M; Turhan, T; Ulusoy, S; Yamazhan, T | 1 |
| Arhin, FF; Belley, A; McKay, GA; Moeck, G; Neesham-Grenon, E; Parr, TR | 1 |
| Alfonso, EC; Almeida, DR; Miller, D | 1 |
| Kim, SY; Lee, YC; Yang, J | 1 |
| Hiratsuka, Y; Kobayakawa, S; Murakami, A; Tochikubo, T; Watabe, Y | 1 |
| Baud, O; Bidet, P; Bingen, E; Biran, V; Bonacorsi, S; Brunel-Meunier, N; Charriaut-Marlangue, C; Gressens, P; Kitzis, MD; Le Saché, N; Pansiot, J; Pham, H | 1 |
| Cars, O; Friberg, LE; Nielsen, EI | 1 |
| Karenchak, LM; Kowalski, RP; Kowalski, TA; Mah, FS; Romanowski, EG; Shanks, RM | 1 |
| Al-Ahmad, A; Ameen, H; Anderson, AC; Hellwig, E; Karygianni, L; Pelz, K; Spitzmüller, B; Wittmer, A | 1 |
| Balla, J; Fehérvári, I; Kertész, A; Nemes, B; P Szabó, R; Szerafin, T; Zsom, L | 1 |
| Beeton, ML; Chalker, VJ; Jones, LC; Maxwell, NC; Spiller, OB | 1 |
| Altun, A; Aydın Kurna, S; Irkec, M; Kökcen, K; Sengor, T; Yalcin, NG; Yuzbasioglu, E | 1 |
| Chen, HC; Huang, CC; Huang, WC; Wu, MF | 1 |
| Arguello, RA; Chevez-Barrios, P; Divatia, MK; Matoba, AY | 1 |
| Allen, GP; Deao, KM; Hill, SA; Schipelliti, SM; Tran, T | 1 |
| Frings, A; Geerling, G; Goerke, P; Holtmann, C; MacKenzie, CR; Roth, M | 1 |
| Chu, N; Gu, Y; Luo, H; Wang, Q; Xiao, Y; Yang, J; Zhang, J | 1 |
1 review(s) available for moxifloxacin and gentamicin
| Article | Year |
|---|---|
Dacryoadenitis and extraocular muscle inflammation associated with contact lens-related Acanthamoeba keratitis: A case report and review of the literature.
Topics: Acanthamoeba Keratitis; Adult; Anti-Bacterial Agents; Antiprotozoal Agents; Benzamidines; Biguanides; Contact Lenses; Dacryocystitis; Drug Therapy, Combination; Eye Infections, Parasitic; Fluoroquinolones; Gentamicins; Humans; Magnetic Resonance Imaging; Male; Microscopy, Confocal; Moxifloxacin; Oculomotor Muscles; Orbital Myositis | 2017 |
25 other study(ies) available for moxifloxacin and gentamicin
| Article | Year |
|---|---|
Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-re
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines; Quinolones; Staphylococcus aureus; Vancomycin; Virginiamycin | 1999 |
In-vitro activity of moxifloxacin combined with other antibacterials against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents; Aza Compounds; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Gentamicins; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rifampin; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2000 |
Activities of antimicrobial agents against intracellular pneumococci.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Fluoroquinolones; Gentamicins; Humans; Ketolides; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Penicillin G; Quinolines; Rifampin; Streptococcus pneumoniae; Tumor Cells, Cultured | 2000 |
Effects of amoxicillin, gentamicin, and moxifloxacin on the hemolytic activity of Staphylococcus aureus in vitro and in vivo.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Blotting, Northern; Blotting, Western; Coloring Agents; Congo Red; Cystic Fibrosis; Fluoroquinolones; Gentamicins; Granuloma; Hemolysis; HLA Antigens; Humans; Leukocyte Elastase; Male; Moxifloxacin; Penicillins; Quinolines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcal Protein A; Staphylococcus aureus | 2001 |
Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; beta-Lactams; Ciprofloxacin; Fluoroquinolones; Gentamicins; Humans; Listeria monocytogenes; Macrophages; Microbial Sensitivity Tests; Moxifloxacin; Quinolines | 2002 |
Activity of beta-lactams (ampicillin, meropenem), gentamicin, azithromycin and moxifloxacin against intracellular Listeria monocytogenes in a 24 h THP-1 human macrophage model.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Cells, Cultured; Colony Count, Microbial; Culture Media; Fluoroquinolones; Gentamicins; Humans; Listeria monocytogenes; Macrophages; Moxifloxacin; Quinolines | 2003 |
Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Fluoroquinolones; Gentamicins; Glycopeptides; Lipoglycopeptides; Lymphoma, Large B-Cell, Diffuse; Macrophages; Mice; Microbial Sensitivity Tests; Microscopy, Electron; Moxifloxacin; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Tumor Cells, Cultured | 2003 |
New real-time PCR-based method for in vitro susceptibility testing of Anaplasma phagocytophilum against antimicrobial agents.
Topics: Ampicillin; Anaplasma phagocytophilum; Anti-Bacterial Agents; Aza Compounds; Azithromycin; DNA, Bacterial; DNA, Ribosomal; Doxycycline; Fluoroquinolones; Genes, rRNA; Gentamicins; Ketolides; Microbial Sensitivity Tests; Moxifloxacin; Polymerase Chain Reaction; Quinolines; Reproducibility of Results; RNA, Bacterial; RNA, Ribosomal, 16S; Sensitivity and Specificity | 2004 |
Efficacy and safety of moxifloxacin as an additive in Optisol-GS a preservation medium for corneal donor tissue.
Topics: Anthraquinones; Anti-Infective Agents; Aza Compounds; Cell Count; Cell Survival; Chondroitin Sulfates; Coloring Agents; Complex Mixtures; Cornea; Culture Media, Serum-Free; Dextrans; Drug Combinations; Endothelium, Corneal; Fluoroquinolones; Gentamicins; Humans; Middle Aged; Moxifloxacin; Organ Preservation; Organ Preservation Solutions; Quinolines; Tissue Donors; Trypan Blue | 2006 |
Moxifloxacin versus ampicillin + gentamicin in the therapy of experimental Listeria monocytogenes meningitis.
Topics: Ampicillin; Animals; Aza Compounds; Disease Models, Animal; Drug Therapy, Combination; Fluoroquinolones; Gentamicins; Humans; Male; Meningitis, Listeria; Moxifloxacin; Quinolines; Rabbits | 2008 |
Assessment by time-kill methodology of the synergistic effects of oritavancin in combination with other antimicrobial agents against Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Drug Synergism; Fluoroquinolones; Gentamicins; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Polysorbates; Quinolines; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Surface-Active Agents; Vancomycin Resistance | 2008 |
Tsukamurella: an emerging opportunistic ocular pathogen.
Topics: Actinomycetales; Actinomycetales Infections; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Conjunctivitis, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Opportunistic Infections; Quinolines; Tobramycin | 2010 |
Safety of moxifloxacin and voriconazole in corneal storage media on porcine corneal endothelial cells.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Cell Count; Cell Survival; Chondroitin Sulfates; Complex Mixtures; Cornea; Cryopreservation; Culture Media, Serum-Free; Dextrans; Endothelium, Corneal; Fluoroquinolones; Gentamicins; Moxifloxacin; Organ Preservation Solutions; Pyrimidines; Quinolines; Swine; Tissue Preservation; Triazoles; Voriconazole | 2010 |
Comparison of the influence of intracameral gentamicin, gatifloxacin, and moxifloxacin on the corneal endothelium in a rabbit model.
Topics: Animals; Anterior Chamber; Anti-Bacterial Agents; Aza Compounds; Endothelium, Corneal; Fluoroquinolones; Gatifloxacin; Gentamicins; Microscopy, Electron, Scanning; Models, Animal; Moxifloxacin; Quinolines; Rabbits | 2010 |
Effect of moxifloxacin combined with cefotaxime compared to cefotaxime-gentamicin combination on prevention of white matter damage associated with Escherichia coli sepsis in neonatal rats.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Aza Compounds; Cefotaxime; Escherichia coli Infections; Fluoroquinolones; Gentamicins; Leukoencephalopathies; Moxifloxacin; Quinolines; Rats; Rats, Sprague-Dawley; Sepsis | 2011 |
Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization.
Topics: Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Cefuroxime; Computer Simulation; Erythromycin; Escherichia coli; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Moxifloxacin; Penicillin G; Quinolines; Streptococcus pyogenes; Vancomycin | 2011 |
In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection.
Topics: Anti-Bacterial Agents; Aza Compounds; Cefazolin; Cefuroxime; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Incidence; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Tobramycin | 2013 |
Antibiotic resistance and capacity for biofilm formation of different bacteria isolated from endodontic infections associated with root-filled teeth.
Topics: Actinomyces; Actinomyces viscosus; Amoxicillin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Clindamycin; Dental Pulp Diseases; Doxycycline; Drug Resistance, Bacterial; Enterococcus faecalis; Fluoroquinolones; Fosfomycin; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Limosilactobacillus fermentum; Moxifloxacin; Penicillin G; Penicillin Resistance; Prevotella; Propionibacterium; Rifampin; Streptococcus mutans; Tetracycline Resistance; Tooth, Nonvital; Vancomycin Resistance | 2014 |
[Infective endocarditis caused by Chlamydia pneumoniae after liver transplantation. Case report].
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Aortic Valve; Aphasia; Brain; Calcineurin; Ceftriaxone; Chlamydia; Coronary Artery Bypass; Drug Administration Schedule; Echocardiography, Transesophageal; Endocarditis, Bacterial; Female; Fluoroquinolones; Gentamicins; Heart Valve Prosthesis Implantation; Humans; Intracranial Embolism; Liver Transplantation; Magnetic Resonance Imaging; Middle Aged; Moxifloxacin; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome | 2015 |
Antibiotic Resistance among Clinical Ureaplasma Isolates Recovered from Neonates in England and Wales between 2007 and 2013.
Topics: Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; England; Epidemiological Monitoring; Fluoroquinolones; Gentamicins; Humans; Infant; Infant, Newborn; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Retrospective Studies; Tetracycline; Ureaplasma; Ureaplasma Infections; Wales | 2016 |
In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Cycloserine; Drug Synergism; Fluoroquinolones; Gentamicins; Humans; Linezolid; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Sputum; Streptomycin | 2018 |
Clinically Significant Enhancement of Voriconazole Efficacy by Moxifloxacin and Gentamicin in Fungal Keratitis.
Topics: Anti-Bacterial Agents; Antifungal Agents; Drug Therapy, Combination; Eye Infections, Fungal; Fluoroquinolones; Gentamicins; Humans; Keratitis; Male; Middle Aged; Moxifloxacin; Treatment Outcome; Voriconazole; Young Adult | 2018 |
In vitro evaluation of antimicrobial resistance selection in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Doxycycline; Drug Resistance, Multiple, Bacterial; Ertapenem; Gentamicins; Gonorrhea; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Neisseria gonorrhoeae | 2021 |
Spectrum and resistance in bacterial infections of the ocular surface in a German tertiary referral center 2009-2019.
Topics: Anti-Bacterial Agents; Bacteria; Drug Resistance, Bacterial; Eye Infections, Bacterial; Female; Gentamicins; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Moxifloxacin; Retrospective Studies; Tertiary Care Centers | 2022 |
Antimicrobial Resistance of Helicobacter Pylori Among Low-resource Chinese Minorities.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; China; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; East Asian People; Female; Gentamicins; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Moxifloxacin; Rifampin | 2023 |